Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® (Avatrombopag) in Adult Patients With Immune Thrombocytopenia (ITP)

NCT04943042 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.

NCT NCT04943042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04943042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® (Avatrombopag) in Adult Patients With Immune Thrombocytopenia (ITP)
Lead sponsor
Swedish Orphan Biovitrum
Phase
Observational
Overall status
Completed
Start date
February 22, 2022
Completion date
June 10, 2025
Enrollment
199 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia, itp